DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By NextGen Healthcare Data Breach
NEWTOWN, PA — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by NextGen Healthcare (“NextGen” or the “Company”) resulting from a data breach that occurred between March 29 and April 14, 2023. The Company learned of suspicious activity on March 30, 2023, but failed to take any defensive measures to timely stop the breach. The data breach affected over 1 million individuals.
Background on NextGen Healthcare
NextGen located in Atlanta, Georgia is a provider of electronic health record software and provides doctors and medical professionals with practice management services.
What happened?
On March 30, 2023, the Company was alerted about a potential data breach. After completing an internal investigation, NextGen determined that client information had been stolen between March 29 and April 14, 2023.
Some of the customer data may have included patient’s names, dates of birth, addresses and social security numbers.
How can I protect my personal data?
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the NextGen data breach.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Web: www.edelson-law.com
About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.